Investor Type | Firm |
Industries | Software (Web Marketplace Saas..) • IT (& TMT) • Media • Education • Businesses Solutions • A.I. (& Big Data) • Food & Beverage • Medical Devices (& Hospital Services) • Life Science |
Stages | Early,Seed |
Investing | United States |
Investment Range | $30,000,000 - $30,000,000 |
Ascent Biomedical Ventures is a New York-based venture capital firm founded in 2004 specializing in providing early and seed-stage funding to startups and companies innovating within the biomedical technology sphere. They primarily focus on investments in medical devices, bio-pharmaceuticals, healthcare services, and IT related to healthcare. The firm identifies cutting-edge companies and technologies that have the potential to significantly impact the life sciences sector and improve patient outcomes. With a commitment to driving growth and value creation, Ascent Biomedical Ventures leverages their financial resources and extensive network to foster innovation and propel the development of high-potential startups. They operate with an investment thesis centered on transformative and scalable solutions within their targeted industries, meticulously selecting opportunities that align with their expertise in Software (including Web Marketplace and SaaS), IT and TMT, Media, Education, Business Solutions, A.I. and Big Data, Food & Beverage, Medical Devices, Hospital Services, and Life Science. Ascent Biomedical Ventures' approach is driven by a combination of deep domain knowledge and a strategic understanding of the unique challenges faced by entrepreneurs in these sectors. Their investment range is standardized, offering a maximum and minimum of $30 million, signaling a commitment to significant financial support to catalyze growth and development for the ventures they back.